Product
IPEC with Cisplatin
1 clinical trial
2 indications
Indication
Ovarian CancerIndication
Primary Peritoneal CancerClinical trial
Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer: A Randomized Phase II TrialStatus: Completed, Estimated PCD: 2020-12-31